Making Babies: Biomedical Technologies, Reproductive Ethics, and Public Policy

CHF 216.60
Auf Lager
SKU
739JO1CACLA
Stock 1 Verfügbar
Geliefert zwischen Do., 25.09.2025 und Fr., 26.09.2025

Details

Each year, roughly a million new cases of cancer appear in the US, and more than 500,000 Americans die annually of premature death. Although medical progress has slowed cancer mortality, its incidence is increasing roughly six times faster than cancer mortality is decreasing. Breast cancer, in particular, has been increasing about one percent each year since 1973. At least two of the factors responsible for this surge in breast cancer are women's use of medically-prescribed synthetic hormones and the exposure of the entire population to chemicals such as dioxin. Both exposures increase the likelihood of breast cancer. Although many ethicists worry about involuntary societal imposition of chemicals such as dioxin, through industrial and agricultural processes, allegedly voluntary exposures also constitute both, a public-health problem and a biomedical-ethics difficulty. Physicians recommend synthetic hormones, for example, to women who apparently take them voluntarily. In the case of in vitro fertilization, doctors prescribe hormones to induce egg production and to increase the chances of reproduction for couples who are unable to have children. Despite the benefits of medical technologies such as hormone stimulation and in vitro fertilization, they also carry great risks. The price that childless women pay, for their opportunity to have children through in vitro fertilization, may be their own increased risk of diseases - such as breast cancer - that are hormone dependent.

Klappentext

The present work tries to show that problematic evaluations of new technologies such as IVF may be as dangerous as no evaluation at all. Because technology assessments may give people a false sense of security, poor ones may serve as a legitimization of premature, dangerous, or misunderstood decisions. Careful analysis of technology assessments may uncover particular epistemological and ethical problems that could misguide public policy. This book is the first to offer an extensive evaluation of four prominent institutional assessments of IVF. This philosophical analysis reveals how inadequate assessments may produce policies that are not in the public's best interests.


Zusammenfassung
`This is a very interesting and richly documented book.'
Medicine, Health Care and Philosophy, 2:1 (1999)


Inhalt
1 Introduction: The Importance of Evaluating Assessments of in Vitro Fertilization.- 2 Overview of Technology Assessment.- 3 In Vitro Fertilization: Contextualizing the Technology.- 4 Ethics and Uncertainty: In Vitro Fertilization and Risks to Women's Health.- 5 In Vitro Fertilization and the Ethics of Nonconservative Medical Care.- 6 Free Informed Consent and in Vitro Fertilization.- 7 Conclusion and Future Trends.

Cart 30 Tage Rückgaberecht
Cart Garantie

Weitere Informationen

  • Allgemeine Informationen
    • Sprache Englisch
    • Gewicht 335g
    • Autor Inmaculada de Melo-Martín
    • Titel Making Babies: Biomedical Technologies, Reproductive Ethics, and Public Policy
    • Veröffentlichung 05.12.2010
    • ISBN 9048150426
    • Format Kartonierter Einband
    • EAN 9789048150427
    • Jahr 2010
    • Größe H235mm x B155mm x T12mm
    • Herausgeber Springer Netherlands
    • Anzahl Seiten 216
    • Auflage Softcover reprint of hardcover 1st edition 1998
    • Lesemotiv Verstehen
    • GTIN 09789048150427

Bewertungen

Schreiben Sie eine Bewertung
Nur registrierte Benutzer können Bewertungen schreiben. Bitte loggen Sie sich ein oder erstellen Sie ein Konto.